PatientsVille.com Logo

Prophylaxis and Femibion

PatientsVille

Prophylaxis Symptoms and Causes

In the early 1980s, when the HIV/AIDS epidemic began, patients rarely lived longer than a few years. But today, there are many effective medicines to fight the infection, and people with HIV have longer, healthier lives.

There are five major types of medicines:

  • Reverse transcriptase (RT) inhibitors - interfere with a critical step during the HIV life cycle and keep the virus from making copies of itself
  • Protease inhibitors - interfere with a protein that HIV uses to make infectious viral particles
  • Fusion inhibitors - block the virus from entering the body's cells
  • Integrase inhibitors - block an enzyme HIV needs to make copies of itself
  • Multidrug combinations - combine two or more different types of drugs into one

These medicines help people with HIV, but they are not perfect. They do not cure HIV/AIDS. People with HIV infection still have the virus in their bodies. They can still spread HIV to others through unprotected sex and needle sharing, even when they are taking their medicines.

NIH: National Institute of Allergy and Infectious Diseases

Check out the latest treatments for prophylaxis

prophylaxis treatment research studies

Femibion clinical trials, surveys and public health registries


Find Drug Side Effect reports



Femibion Side Effects

Premature Baby (17)
Ventricular Septal Defect (7)
Pregnancy (6)
Hyperbilirubinaemia Neonatal (4)
Haemangioma Congenital (4)
Small For Dates Baby (3)
Atrial Septal Defect (3)
Maternal Exposure During Pregnancy (2)
Foetal Exposure During Pregnancy (2)
Hyperbilirubinaemia (1)
Hypospadias (1)
Inguinal Hernia (1)
Vaginal Haemorrhage (1)
Neonatal Disorder (1)
Bradycardia Neonatal (1)
Haemangioma (1)
Heart Rate Decreased (1)
Hydrocele (1)
Anaemia Neonatal (1)
Congenital Aortic Valve Incompetence (1)
Congenital Aortic Valve Stenosis (1)
Cyanosis Neonatal (1)
Cardiac Murmur (1)
Abortion Missed (1)
Pyelonephritis (1)
Anaphylactic Shock (1)
Neonatal Respiratory Distress Syndrome (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Prophylaxis Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
Condition: Abortion, Habitual
Interventions: Drug: Fragmin P Forte (dalteparin sodium);   Dietary Supplement: Multivitamin supplement
Outcome Measures: ongoing intact pregnancy at 24 weeks of gestation;   late pregnancy complication, defined as at least one of the following: preterm delivery, placenta insufficiency, intrauterine growth retardation, preeclampsia and abruptio placentae;   foetus with structural anomalies;   side effects of dalteparin therapy (e.g. thrombocytopenia, osteoporosis, haemorrhage);   life birth;   preterm delivery (< 37 weeks of gestation)